Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Avian Dis ; 59(1): 165-70, 2015 Mar.
Article in English | MEDLINE | ID: mdl-26292553

ABSTRACT

Electron-beam (eBeam) irradiation technology has a variety of applications in modern society. The underlying hypothesis was that eBeam-inactivated Salmonella enterica serovar Enteritidis (SE) cells can serve as a vaccine to control SE colonization and shedding in poultry birds. An eBeam dose of 2.5 kGy (kilograys) was used to inactivate a high-titer (10(8) colony-forming units [CFU]) preparation of SE cells. Microscopic studies revealed that the irradiation did not damage the bacterial cell membranes. The vaccine efficacy was evaluated by administering the eBeam-killed SE cells intramuscularly (1 x 10(6) CFU/bird) into 50-wk-old single comb white leghorn hens. On day 14 postvaccination, the hens were challenged orally with live SE cells (1 x 10(9) CFU) and SE colonization of liver, spleen, ceca, and ovaries determined on day 23. Blood samples were collected on days 0, 14, and 23 postvaccination and the sera were analyzed to quantify SE-specific IgG titers. The vaccinated chickens exhibited significantly (P < 0.0001) higher SE-specific IgG antibody responses and reduced SE ceca colonization (1.46 ± 0.39 logi10 CFU/g) compared to nonvaccinated birds (5.32 ± 0.32 log10 CFU/g). They also exhibited significantly lower SE colonization of the ovaries (1/30), spleen (3/30), liver (4/30), and ceca (7/30) compared to nonvaccinated birds. These results provide empirical evidence that eBeam-based SE vaccines are immunogenic and are capable of protecting chickens against SE colonization. The advantages of eBeam-based vaccine technology are that it is nonthermal, avoids the use of formalin, and can be used to generate inactivated vaccines rapidly to address strain-specific infections in farms or flocks.


Subject(s)
Bacterial Vaccines/immunology , Chickens , Molting , Salmonella Infections, Animal/prevention & control , Salmonella enteritidis/radiation effects , Animals , Antibodies, Bacterial/blood , Female , Immunoglobulin G/blood , Vaccines, Inactivated
2.
Poult Sci ; 93(2): 267-72, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24570447

ABSTRACT

Linalool is a natural plant-product used in perfumes, cosmetics, and flavoring agents. Linalool has proven antimicrobial and insect-repellent properties, which indicate it might be useful for control of enteropathogens or insect pests in poultry production. However, there are no published reports that linalool may be safely administered to or tolerated by chickens. Linalool was added to the diets of day-of-hatch chicks, and they were fed linalool-supplemented diets for 3 wk. We studied the effects of linalool on serum chemistry, gross pathology, feed conversion, and relative liver weights. Linalool had a dramatic negative dose-dependent effect on feed conversion at concentrations in the feed exceeding 2% linalool, but not on gross pathology. Liver weights were significantly increased in the 5% linalool-treated birds. There was a statistical effect on blood glucose, but this parameter remained below the cut-offs for elevated serum glucose, and the result is likely of no biological significance. Linalool caused serum aspartate aminotransferase (AST) levels to increase, but it did not increase serum gamma-glutamyl transferase levels. The linalool effect on AST was dose-dependent, but in linalool doses between 0.1 and 2% of the feed, AST was not elevated beyond normal parameters. Linalool at 2% or less may be safely added to chicken feed. We suggest future studies to evaluate the addition of linalool to the litter, where it may be used as an antimicrobial or an insect repellent or to produce a calming effect.


Subject(s)
Anti-Infective Agents/adverse effects , Chickens/growth & development , Chickens/metabolism , Insecticides/adverse effects , Monoterpenes/adverse effects , Oils, Volatile/adverse effects , Acyclic Monoterpenes , Animal Feed/analysis , Animal Nutritional Physiological Phenomena , Animals , Anti-Infective Agents/administration & dosage , Blood Chemical Analysis/veterinary , Diet/veterinary , Dietary Supplements/analysis , Energy Metabolism , Insecticides/administration & dosage , Monoterpenes/administration & dosage , Ocimum basilicum/chemistry , Oils, Volatile/administration & dosage , Organ Size , Pathology , Weight Gain
3.
Dev Comp Immunol ; 34(11): 1139-43, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20599554

ABSTRACT

CD40 is mainly expressed by professional antigen-presenting cells (APCs). Its ligand, CD40L, is transiently expressed on activated CD4(+) T-cells. CD40-CD40L interactions mediate T-cell help to APCs and provide crucial signals for affinity maturation and B-cell class switching. In mammals, agonistic monoclonal anti-CD40 antibodies (mAbs) mimic the effects of CD40L on APCs, leading to enhanced T-cell priming and expansion, increased antibody production and class switching. In this study, we describe agonistic anti-chicken CD40 mAb 2C5. This mAb detected CD40 on primary chicken B-cells and macrophages, DT40 B-cells, and HD11 macrophages, induced NO synthesis in HD11 macrophages, and stimulated DT40 B-cell proliferation. These observations demonstrated at least partial functional equivalence of 2C5 to chicken CD154. This mAb may therefore constitute a new tool to study the role of CD40 in the chicken immune system, and its agonistic effects suggest that it could also be used as an adjuvant.


Subject(s)
Antibodies, Monoclonal/metabolism , Avian Proteins/metabolism , B-Lymphocytes/metabolism , CD40 Antigens/metabolism , Macrophages/metabolism , Adjuvants, Immunologic , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/isolation & purification , Antibodies, Monoclonal/pharmacology , Avian Proteins/agonists , Avian Proteins/genetics , Avian Proteins/immunology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , B-Lymphocytes/pathology , CD40 Antigens/agonists , CD40 Antigens/genetics , CD40 Antigens/immunology , CD40 Ligand/immunology , Cell Proliferation/drug effects , Cells, Cultured , Chickens , Genetic Engineering , Ligands , Macrophages/drug effects , Macrophages/immunology , Macrophages/pathology , Nitric Oxide/metabolism , Protein Structure, Tertiary/genetics
4.
Foodborne Pathog Dis ; 3(4): 461-5, 2006.
Article in English | MEDLINE | ID: mdl-17199529

ABSTRACT

An experimental chlorate product that targets the respiratory nitrate reductase enzyme of bacteria such as Salmonella and Escherichia coli has shown promising results in reducing concentrations of these bacteria in the gut of food animals. Because expression of the target enzyme is induced by nitrate, we administered short-duration, low level nitrate or nitroethane preconditioning treatments to finishing swine to see if these would enhance the ability of an experimental chlorate product to kill these bacteria. Results from these studies showed that preconditioning the gut microflora of swine with low levels of nitrate or nitrocompounds enhanced (more than tenfold) the ability of the chlorate product to kill Salmonella and E. coli, but not Campylobacter. Further studies are needed before these compounds can be fed as feed additives to animals, although it is likely that nitrate preconditioning may be more near to market than the nitrocompounds, which may require more comprehensive review by regulatory authorities.


Subject(s)
Anti-Bacterial Agents/pharmacology , Chlorates/pharmacology , Escherichia coli/drug effects , Nitrate Reductase/metabolism , Nitrogen Compounds/administration & dosage , Salmonella typhimurium/drug effects , Swine Diseases/prevention & control , Animal Feed , Animals , Campylobacter/drug effects , Campylobacter/enzymology , Campylobacter/growth & development , Escherichia coli/enzymology , Escherichia coli/growth & development , Ethane/administration & dosage , Ethane/analogs & derivatives , Ethane/pharmacology , Food Microbiology , Humans , Nitrates/administration & dosage , Nitrates/pharmacology , Nitrogen Compounds/pharmacology , Nitroparaffins/administration & dosage , Nitroparaffins/pharmacology , Random Allocation , Salmonella typhimurium/enzymology , Salmonella typhimurium/growth & development , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...